Skip to content

A randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxine treatment for cervical dystonia (StimTox-CD).

A randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxine treatment for cervical dystonia (StimTox-CD). - StimTox-CD

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013524
Enrollment
66
Registered
2018-02-16
Start date
2017-07-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G24.3

Interventions

Group 1: effective neurostimulation via implanted bilateral pallidal electrodes according to international clinical standards (90 µs pulse width, 130 Hz frequency, amplitude and choice of electrode co

Sponsors

Universitätsklinikum Würzburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: * Diagnosis of primary cervical dystonia >= 2 years * Severity of dystonia >= 20 points on the TWSTRS total and >= 15 points on the TWSTRS motor scale * Age >= 18 years and = 25% score reduction on the TWSTRS motor scale at 4 weeks after a test injection. * Last injection of BoNT A >= 12 weeks before screening * Willingness to undergo pallidal deep brain stimulation surgery * Written informed consent for the participation after written and verbal information by trail physician

Exclusion criteria

Exclusion criteria: * Severity of dystonia 25 ) (earlier episodes of major depression in remission are not excluded) * Dementia or minimal cognitive impairment (Mattis Score = 125) * Acute psychosis (benign hallucinations or earlier psychotic episodes are not excluded) * Any medical or psychological problems which may interfere with a smooth conduction of the study protocol (e.g. cancer with a limited life expectancy) * Analphabetism * Drug or alcohol addiction * Surgical contraindications against pallidal neurostimulation * Fertile women not using adequate contraceptive methods (hormonal contraception, spiral, surgical sterilisation) * Pregnancy or breast feeding * Simultaneous participation in another clinical treatment trial

Design outcomes

Primary

MeasureTime frame
Difference in TWSTRS total score between baseline and 6 months after stereotactic surgery with bilateral implantation of pallidal stimulation electrodes and generator under optimal therapy

Secondary

MeasureTime frame
* Difference in Craniocervical Dystonia Questionnaire (CDQ-24) between baseline and 6 months after surgery under optimal therapy * Changes in TWSTRS motor score * Changes in TSUI score * Changes in SF-36 * Frequency and severity spontaneously reported adverse events/reactions under BoNT A injections and sham stimulation or neurostimulation and sham injections

Countries

Germany

Contacts

Public ContactLeypold Christine

Universitätsklinikum Würzburg Neurologische Klinik und Poliklinik

Leypold_C@ukw.de0931-201-23529

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026